Cargando…

Drug Resistance and Novel Therapies in Cancers in 2020

Detalles Bibliográficos
Autor principal: Wang, Zhixiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913530/
https://www.ncbi.nlm.nih.gov/pubmed/36765674
http://dx.doi.org/10.3390/cancers15030717
_version_ 1784885450161258496
author Wang, Zhixiang
author_facet Wang, Zhixiang
author_sort Wang, Zhixiang
collection PubMed
description
format Online
Article
Text
id pubmed-9913530
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-99135302023-02-11 Drug Resistance and Novel Therapies in Cancers in 2020 Wang, Zhixiang Cancers (Basel) Editorial MDPI 2023-01-24 /pmc/articles/PMC9913530/ /pubmed/36765674 http://dx.doi.org/10.3390/cancers15030717 Text en © 2023 by the author. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Editorial
Wang, Zhixiang
Drug Resistance and Novel Therapies in Cancers in 2020
title Drug Resistance and Novel Therapies in Cancers in 2020
title_full Drug Resistance and Novel Therapies in Cancers in 2020
title_fullStr Drug Resistance and Novel Therapies in Cancers in 2020
title_full_unstemmed Drug Resistance and Novel Therapies in Cancers in 2020
title_short Drug Resistance and Novel Therapies in Cancers in 2020
title_sort drug resistance and novel therapies in cancers in 2020
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913530/
https://www.ncbi.nlm.nih.gov/pubmed/36765674
http://dx.doi.org/10.3390/cancers15030717
work_keys_str_mv AT wangzhixiang drugresistanceandnoveltherapiesincancersin2020